1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 4:P values from the assessment of TTP, peak opacification, and AUC differences when comparing injection protocols: variable concentration*
TTP Capillary TTP Arterial TTP Venous Peak Capillary Peak Arterial Peak Venous AUC Capillary AUC Arterial AUC Venous Overall .2235 <.0001 .0072 .0432 .0040 .0035 .0789 .0009 .1901 100%–25% <.0001 .0086 .0186 .0023 .0008 .0004 100%–50% .0977 .0132 .0122 .0015 .0038 .0064 100%–75% .2582 .9593 .1971 .1609 .1356 .6618 25%–50% .0004 .8427 .8466 .8578 .4980 .2259 25%–75% <.0001 .0077 .2277 .0517 .0245 .0011 50%–75% .0093 .0118 .1656 .0360 .0949 .0166
* P values for paired contrasts were not calculated if no overall significant difference of the group was observed.